Open Monoclonal Technology

14 articles about Open Monoclonal Technology

• Ligand Acquires Bay Area Antibody Drug Discovery Firm OMT for $178 Million

  12/18/2015

• Open Monoclonal Technology, Inc. Announces OmniAb License To Seattle Genetics

  11/2/2015

• Open Monoclonal Technology, Inc. And ARMO BioSciences Announce Anti-PD1 Antibody And Omniab Platform License Agreement

  10/16/2015

• Open Monoclonal Technology, Inc. Announces OmniAb Alliance With Five Prime

  10/6/2015

• Open Monoclonal Technology, Inc. Announces OmniAb Alliance With Amgen

  6/15/2015

• Open Monoclonal Technology, Inc. Grants OmniAb License To University of Nottingham

  3/18/2015

• Open Monoclonal Technology, Inc. Announces OmniAb Alliance With Celgene

  3/11/2015

• Open Monoclonal Technology, Inc. Grants Unlimited OmniRat, OmniMouse And OmniFlic License

  10/1/2014

• Open Monoclonal Technology, Inc. Provides Important Intellectual Property Update

  4/22/2014

• Open Monoclonal Technology, Inc. Grants Unlimited Omnirat, Omnimouse And Omniflic Access To Another Global Pharmaceutical Company

  1/7/2014

• Roche And Genentech Acquire Unlimited Access To Open Monoclonal Technology, Inc.’s Omnirat®

  12/18/2013

• EMD Serono and EMD Group (EMD Millipore (Massachusetts)) Expand Collaboration to Include Unlimited Access to OmniRat® Human Antibody Platform

  10/28/2013

• Symphogen A/S and Open Monoclonal Technology, Inc. Announce Collaboration

  10/15/2013

• Company Profile for Open Monoclonal Technology, Inc.

  10/11/2013